Literature DB >> 10996600

Acetylcholinesterase-independent action of diisopropyl-flurophosphate in the rat aorta.

S L Lim1, M K Sim, W K Loke.   

Abstract

Recent studies have shown that many organophosphates can bind competitively and noncompetitively to membrane muscarinic receptors. The present study investigated the responses of the rat aortic rings to diisopropyl-flurophosphate (DFP), an organophsophorus cholinesterase inhibitor, and the possible involvement of muscarinic receptors. DFP caused a concentration-dependent contraction when added cumulatively from 10(-8) to 10(-4) M. This contraction was inhibited in a noncompetitive manner by high concentrations of atropine (1.5 x 10(-6) and 1.8 x 10(-6) M) but was unaffected by similar concentrations of selective muscarinic receptor subtype antagonists, pirenzepine, 11-2[2-[(diethylamino)methyl]-1-piperidinyl]acetyl-5, 11-dihydro-6H-rido[2,3-b][1,4]benzodiazepin-6-one (AF-DX116) and 4-Diphenylacetoxy-N-methyl piperidine methiodide (4-DAMP). Phentolamine, an alpha-adrenoceptor antagonist, was able to inhibit the DFP-induced contraction in a noncompetitive manner at a concentration of 10(-7) M. These findings suggested that the DFP-induced contraction in the rat aortic rings was mediated by norepinephrine that was released from sympathetic nerve terminals present in the aortic rings.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996600     DOI: 10.1016/s0014-2999(00)00629-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Paraoxon attenuates vascular smooth muscle contraction through inhibiting Ca2+ influx in the rabbit thoracic aorta.

Authors:  Shouhong Zhou; Liying Liu; Xuhong Yang; Shujin Wu; Gengrong Chen
Journal:  J Biomed Biotechnol       Date:  2010-04-22

2.  The effect of chlorpyrifos on isolated thoracic aorta in rats.

Authors:  Ebru Yıldırım; Emine Baydan; Murat Kanbur; Oğuz Kul; Miyase Cınar; Hüsamettin Ekici; Nurgül Atmaca
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.